KIT ANTI-ESTREPTOLISINA O OPTILITE®.
Mexico·Clase I·III. DIAGNOSTIC AGENTS·INSUMOS PARA LA SALUD, S.A. DE C.V.·Registered September 24, 2018EL KIT ANTI-ESTREPTOLISINA O OPTILITE® TIENE COMO OBJETIVO LA CUANTIFICACIÓN IN VITRO DE LA ANTI-ESTREPTOLISINA O EN SUERO, EN EL ANALIZADOR OPTILITE® DE BINDING SITE. ESTA PRUEBA SE DEBE USAR JUNTO CON OTRAS DETERMINACIONES CLÍNICAS Y DE LABORATORIO. AG
THE ANTI-STREPTOLYSIN KIT OR OPTILITE AIMS AT IN VITRO QUANTIFICATION OF ANTI-STREPTOLYSIN OR IN SERUM, IN THE BINDING SITE OPTILITE®® ANALYZER. THIS TEST SHOULD BE USED IN CONJUNCTION WITH OTHER CLINICAL AND LABORATORY DETERMINATIONS. AG
- Risk Class / Clase de Riesgo
- Clase I
- Product Type (Spanish)
- III. AGENTES DE DIAGNÓSTICO
- Product Type (English)
- III. DIAGNOSTIC AGENTS
- Trade Name (Spanish)
- REACTIVO PARA LA DETERMINACIÓN DE ANTI-ESTREPTOLISINA O.
- Trade Name (English)
- REAGENT FOR THE DETERMINATION OF ANTI-STREPTOLYSIN O.
- Analysis ID
- 2243R2018 SSA
- Registration Date
- September 24, 2018
- Name (Spanish)
- INSUMOS PARA LA SALUD, S.A. DE C.V.
- Name (English)
- INSUMOS PARA LA SALUD, S.A. DE C.V.
Access comprehensive regulatory information for KIT ANTI-ESTREPTOLISINA O OPTILITE®. (ANTI-STREPTOLYSIN KIT O OPTILITIS®.) in the Mexico medical device market through Pure Global AI's free database. This Clase I medical device is registered under COFEPRIS analysis ID 2243R2018 SSA and manufactured by INSUMOS PARA LA SALUD, S.A. DE C.V.. The device was registered on September 24, 2018.
This page provides complete registration details including product type (III. DIAGNOSTIC AGENTS), manufacturer information, and regulatory compliance data from the official Mexico COFEPRIS medical device database. Pure Global AI offers free access to Mexico's complete medical device registry with bilingual Spanish/English support, helping global MedTech companies navigate COFEPRIS regulations efficiently.